Literature DB >> 29726591

Psychosis screening practices in schools: A survey of school-based mental health providers.

Emily R Kline1, Cole Chokran1, Janine Rodenhiser-Hill1, Larry J Seidman1, Kristen A Woodberry1.   

Abstract

AIM: Many school districts in the United States employ mental health professionals to provide assessment, counselling and crisis interventions within the school setting; however, little is known about actual clinical practices of psychosis screening in schools. The aim of the present study is to examine attitudes and practices regarding psychosis screening among school mental health providers in metropolitan Boston, Massachusetts.
METHODS: School-based mental health clinicians (N = 100) completed an anonymous survey assessing familiarity, screening, and involvement with psychosis and psychosis risk prior to attending trainings on psychosis.
RESULTS: Providers reported screening for psychosis less often than other mental health problems and rated themselves as less confident treating psychosis relative to other mental health concerns. Frequency of screening for psychosis was significantly associated with familiarity with psychosis assessment and case management, confidence providing treatment for individuals experiencing psychosis, and the number of students with or at risk for psychosis with whom providers had been involved. Frequency of screening for psychosis was not associated with years of practice, suggesting that both novice and experienced school-based providers may benefit from training on this issue.
CONCLUSIONS: Community outreach via school-based provider training on assessment and management of psychosis may help to increase providers' understanding of psychosis and increase the practice of verbal or written screening for psychosis and psychosis risk within schools.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  adolescent; psychotic disorders; public health; schools

Mesh:

Year:  2018        PMID: 29726591      PMCID: PMC6215754          DOI: 10.1111/eip.12672

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  15 in total

1.  Causes and consequences of duration of untreated psychosis in schizophrenia.

Authors:  R J Drake; C J Haley; S Akhtar; S W Lewis
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

2.  Duration of untreated psychosis predicts treatment outcome in an early psychosis program.

Authors:  K Black; L Peters; Q Rui; H Milliken; D Whitehorn; L C Kopala
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

3.  Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B).

Authors:  Rachel L Loewy; Rahel Pearson; Sophia Vinogradov; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-04-20       Impact factor: 4.939

4.  Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000.

Authors:  G P Amminger; M G Harris; P Conus; M Lambert; K S Elkins; H-P Yuen; P D McGorry
Journal:  Acta Psychiatr Scand       Date:  2006-11       Impact factor: 6.392

Review 5.  Global burden of disease in young people aged 10-24 years: a systematic analysis.

Authors:  Fiona M Gore; Paul J N Bloem; George C Patton; Jane Ferguson; Véronique Joseph; Carolyn Coffey; Susan M Sawyer; Colin D Mathers
Journal:  Lancet       Date:  2011-06-07       Impact factor: 79.321

6.  Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth.

Authors:  Kristen A Woodberry; Rachael A Serur; Sean B Hallinan; Raquelle I Mesholam-Gately; Anthony J Giuliano; Joanne D Wojcik; Matcheri S Keshavan; Jean A Frazier; Jill M Goldstein; Martha E Shenton; Robert W McCarley; Larry J Seidman
Journal:  Schizophr Res       Date:  2014-06-10       Impact factor: 4.939

7.  The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population.

Authors:  Helga K Ising; Wim Veling; Rachel L Loewy; Marleen W Rietveld; Judith Rietdijk; Sara Dragt; Rianne M C Klaassen; Dorien H Nieman; Lex Wunderink; Don H Linszen; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2012-04-19       Impact factor: 9.306

Review 8.  School-based approaches to reducing the duration of untreated psychosis.

Authors:  Jason Schiffman; Sharon Hoover Stephan; L Elliot Hong; Gloria Reeves
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2015-01-20

Review 9.  Psychosis risk screening: a systematic review.

Authors:  Emily Kline; Jason Schiffman
Journal:  Schizophr Res       Date:  2014-07-14       Impact factor: 4.939

Review 10.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

View more
  4 in total

1.  Equity in Mental Health Services for Youth at Clinical High Risk for Psychosis: Considering Marginalized Identities and Stressors.

Authors:  Joseph S DeLuca; Derek M Novacek; Laura H Adery; Shaynna N Herrera; Yulia Landa; Cheryl M Corcoran; Elaine F Walker
Journal:  Evid Based Pract Child Adolesc Ment Health       Date:  2022-03-23

2.  Reducing Stigma Among Youth at Risk for Psychosis: A Call to Action.

Authors:  Joseph S DeLuca; Lawrence H Yang; Alicia A Lucksted; Philip T Yanos; Jordan DeVylder; Deidre M Anglin; Yulia Landa; Cheryl M Corcoran
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

3.  Screening for Early Emerging Mental Experiences (SEE ME): A Model to Improve Early Detection of Psychosis in Integrated Primary Care.

Authors:  Kristen A Woodberry; Kelsey A Johnson; Lydia A Shrier
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

Review 4.  Advances in clinical staging, early intervention, and the prevention of psychosis.

Authors:  Tina Gupta; Vijay A Mittal
Journal:  F1000Res       Date:  2019-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.